Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies

A. Rajan; A. Berns; U. Ringborg; J. Celis; B. Ponder; C. Caldas; D. Livingston; R. G. Bristow; T. T. Hecht; T. Tursz; H. van Luenen; P. Bono; T. Helander; K. Seamon; J. F. Smyth; D. Louvard; A. Eggermont; W. H. van Harten

doi:10.1016/j.molonc.2015.12.007

Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies

A. Rajan
, A. Berns
, U. Ringborg
, J. Celis
, B. Ponder
, C. Caldas
, D. Livingston
, R. G. Bristow
, T. T. Hecht
, T. Tursz
, H. van Luenen
, P. Bono
, T. Helander
, K. Seamon
, J. F. Smyth
, D. Louvard
, A. Eggermont
, W. H. van Harten

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel recenseren › peer review

11 Citaten (Scopus)

Samenvatting

Comprehensive Cancer Centres (CCCs) serve as critical drivers for improving cancer survival. In Europe, we have developed an Excellence Designation System (EDS) consisting of criteria to assess "excellence" of CCCs in translational research (bench to bedside and back), with the expectation that many European CCCs will aspire to this status.

Originele taal-2	Engels
Pagina's (van-tot)	645-651
Aantal pagina's	7
Tijdschrift	Molecular oncology
Volume	10
Nummer van het tijdschrift	5
DOI's	https://doi.org/10.1016/j.molonc.2015.12.007
Status	Gepubliceerd - 1 mei 2016
Extern gepubliceerd	Ja

Toegang tot document

10.1016/j.molonc.2015.12.007

Citeer dit

Rajan, A., Berns, A., Ringborg, U., Celis, J., Ponder, B., Caldas, C., Livingston, D., Bristow, R. G., Hecht, T. T., Tursz, T., van Luenen, H., Bono, P., Helander, T., Seamon, K., Smyth, J. F., Louvard, D., Eggermont, A., & van Harten, W. H. (2016). Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies. Molecular oncology, 10(5), 645-651. https://doi.org/10.1016/j.molonc.2015.12.007

@article{aa03c1d292114dc585ca279a14d634f6,

title = "Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies",

abstract = "Comprehensive Cancer Centres (CCCs) serve as critical drivers for improving cancer survival. In Europe, we have developed an Excellence Designation System (EDS) consisting of criteria to assess {"}excellence{"} of CCCs in translational research (bench to bedside and back), with the expectation that many European CCCs will aspire to this status.",

keywords = "Excellence, Performance assessment, Quality improvement, Translational research",

author = "A. Rajan and A. Berns and U. Ringborg and J. Celis and B. Ponder and C. Caldas and D. Livingston and Bristow, \{R. G.\} and Hecht, \{T. T.\} and T. Tursz and \{van Luenen\}, H. and P. Bono and T. Helander and K. Seamon and Smyth, \{J. F.\} and D. Louvard and A. Eggermont and \{van Harten\}, \{W. H.\}",

note = "Publisher Copyright: {\textcopyright} 2015 The Authors.",

year = "2016",

month = may,

day = "1",

doi = "10.1016/j.molonc.2015.12.007",

language = "English",

volume = "10",

pages = "645--651",

journal = "Molecular oncology",

issn = "1574-7891",

publisher = "John Wiley and Sons Ltd",

number = "5",

}

Rajan, A, Berns, A, Ringborg, U, Celis, J, Ponder, B, Caldas, C, Livingston, D, Bristow, RG, Hecht, TT, Tursz, T, van Luenen, H, Bono, P, Helander, T, Seamon, K, Smyth, JF, Louvard, D, Eggermont, A & van Harten, WH 2016, 'Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies', Molecular oncology, vol. 10, nr. 5, blz. 645-651. https://doi.org/10.1016/j.molonc.2015.12.007

TY - JOUR

T1 - Excellent translational research in oncology

T2 - A journey towards novel and more effective anti-cancer therapies

AU - Rajan, A.

AU - Berns, A.

AU - Ringborg, U.

AU - Celis, J.

AU - Ponder, B.

AU - Caldas, C.

AU - Livingston, D.

AU - Bristow, R. G.

AU - Hecht, T. T.

AU - Tursz, T.

AU - van Luenen, H.

AU - Bono, P.

AU - Helander, T.

AU - Seamon, K.

AU - Smyth, J. F.

AU - Louvard, D.

AU - Eggermont, A.

AU - van Harten, W. H.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Comprehensive Cancer Centres (CCCs) serve as critical drivers for improving cancer survival. In Europe, we have developed an Excellence Designation System (EDS) consisting of criteria to assess "excellence" of CCCs in translational research (bench to bedside and back), with the expectation that many European CCCs will aspire to this status.

AB - Comprehensive Cancer Centres (CCCs) serve as critical drivers for improving cancer survival. In Europe, we have developed an Excellence Designation System (EDS) consisting of criteria to assess "excellence" of CCCs in translational research (bench to bedside and back), with the expectation that many European CCCs will aspire to this status.

KW - Excellence

KW - Performance assessment

KW - Quality improvement

KW - Translational research

UR - https://www.scopus.com/pages/publications/84953791158

U2 - 10.1016/j.molonc.2015.12.007

DO - 10.1016/j.molonc.2015.12.007

M3 - Review article

C2 - 26797050

AN - SCOPUS:84953791158

SN - 1574-7891

VL - 10

SP - 645

EP - 651

JO - Molecular oncology

JF - Molecular oncology

IS - 5

ER -

Excellent translational research in oncology: A journey towards novel and more effective anti-cancer therapies

Samenvatting

Toegang tot document

Vingerafdruk

Citeer dit